Metogest

Metogest (INN, USAN) (developmental code name SC-14207), also known as 16,16-dimethyl-19-nortestosterone, is a steroidal antiandrogen that was patented in 1975 and investigated as a treatment for acne but was never marketed.[1][2][3]

Metogest

Clinical data
ATC code	None
Identifiers
IUPAC name 17β-Hydroxy-16,16-dimethylestr-4-en-3-one
CAS Number	52279-58-0^Y
PubChem CID	9839398
ChemSpider	8015116
UNII	BPY4IK3W14
CompTox Dashboard (EPA)	DTXSID00200306
Chemical and physical data
Formula	C20H30O2
Molar mass	302.458 g·mol^−1
3D model (JSmol)	Interactive image
SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1CC([C@@H]2O)(C)C)CCC4=CC(=O)CC[C@H]34
InChI InChI=1S/C20H30O2/c1-19(2)11-17-16-6-4-12-10-13(21)5-7-14(12)15(16)8-9-20(17,3)18(19)22/h10,14-18,22H,4-9,11H2,1-3H3/t14-,15+,16+,17-,18-,20-/m0/s1 Key:JYCITEUSLNKPHC-URNBORRASA-N

See also

• Steroidal antiandrogen
• List of steroidal antiandrogens

References

1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 816–. ISBN 978-1-4757-2085-3.
2. R.A. Hill; H.L.J. Makin; D.N. Kirk; G.M. Murphy (23 May 1991). Dictionary of Steroids. CRC Press. pp. 676–. ISBN 978-0-412-27060-4.
3. J. Horsky; J. Presl (6 December 2012). Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 112–. ISBN 978-94-009-8195-9.